Varian Medical Systems, Inc. (VAR)’s Trend Up, Especially After Today’s 52-Week High Milestone

July 17, 2017 - By Hazel Jackson

Investors sentiment increased to 0.9 in Q4 2016. Its up 0.01, from 0.89 in 2016Q3. It increased, as 38 investors sold Varian Medical Systems, Inc. shares while 188 reduced holdings. 59 funds opened positions while 144 raised stakes. 88.84 million shares or 2.22% less from 90.86 million shares in 2016Q3 were reported.
Dekabank Deutsche Girozentrale invested in 0.08% or 86,250 shares. Whittier Trust Communications Of Nevada Inc stated it has 0.02% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Stephens Ar holds 5,147 shares or 0.02% of its portfolio. Robeco Institutional Asset Mgmt Bv holds 0.1% in Varian Medical Systems, Inc. (NYSE:VAR) or 147,368 shares. Intrust Bank Na has 2,760 shares. First Republic Inv Mngmt invested 0% in Varian Medical Systems, Inc. (NYSE:VAR). Raymond James Trust Na invested 0.02% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Aberdeen Asset Mgmt Public Limited Liability Company Uk holds 0.01% or 28,313 shares in its portfolio. Ledyard Savings Bank invested in 2,150 shares. Confluence Wealth Mngmt Ltd Liability Company holds 2,519 shares or 0.11% of its portfolio. Tiaa Cref Invest Mgmt Lc stated it has 276,786 shares. Conning Inc invested 0.01% in Varian Medical Systems, Inc. (NYSE:VAR). Amica Mutual Insurance holds 0.05% or 6,812 shares in its portfolio. Tarbox Grp Inc invested in 0% or 6 shares. 52 were reported by Bessemer Grp Inc.

Since February 22, 2017, it had 0 insider purchases, and 14 sales for $12.71 million activity. Shares for $75,758 were sold by KUO JOHN W. LARET MARK R had sold 1,428 shares worth $147,761 on Thursday, June 8. $326,902 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares were sold by BOSTROM SUSAN L. GUERTIN TIMOTHY E also sold $1.65 million worth of Varian Medical Systems, Inc. (NYSE:VAR) on Friday, June 9.

The stock of Varian Medical Systems, Inc. (NYSE:VAR) hit a new 52-week high and has $115.52 target or 9.00 % above today’s $105.98 share price. The 9 months bullish chart indicates low risk for the $9.88 billion company. The 1-year high was reported on Jul, 17 by Barchart.com. If the $115.52 price target is reached, the company will be worth $889.20 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

About 254,149 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since July 17, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on July, 26. They expect $0.94 earnings per share, down 22.95 % or $0.28 from last year’s $1.22 per share. VAR’s profit will be $87.61 million for 28.19 P/E if the $0.94 EPS becomes a reality. After $0.89 actual earnings per share reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 5.62 % EPS growth.

Varian Medical Systems, Inc. (NYSE:VAR) Ratings Coverage

Among 10 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Varian Medical Systems Inc. had 20 analyst reports since August 27, 2015 according to SRatingsIntel. Brean Capital maintained it with “Buy” rating and $87 target in Thursday, April 28 report. The firm has “Buy” rating by Jefferies given on Friday, July 14. The firm has “Sell” rating by Evercore given on Thursday, January 26. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Hold” rating by RBC Capital Markets on Wednesday, June 21. Citigroup upgraded the stock to “Buy” rating in Monday, May 8 report. Goldman Sachs downgraded it to “Sell” rating and $76 target in Monday, September 28 report. The stock has “Neutral” rating by Citigroup on Thursday, November 12. The rating was maintained by Barrington Research on Friday, January 27 with “Outperform”. RBC Capital Markets maintained the shares of VAR in report on Monday, January 23 with “Sector Perform” rating. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Neutral” rating given on Wednesday, September 28 by Robert W. Baird.

More recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: Zacks.com which released: “Varian Rides on Oncology and Proton Therapy Businesses” on June 28, 2017. Also Nasdaq.com published the news titled: “Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards …” on July 07, 2017. Gurufocus.com‘s news article titled: “Smithbridge Asset Management Inc Buys InterDigital Inc, McKesson Corp …” with publication date: July 17, 2017 was also an interesting one.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company has market cap of $9.88 billion. The Firm also has Varian Particle Therapy and the activities of the Ginzton Technology Center (GTC). It has a 33.45 P/E ratio. The Company’s VPT business develops, designs, makes, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.